Given the heterogeneity in regions showing tau abnormality at the individual level across the AD continuum, we then evaluated if the measure of tau spatial extent could yield stronger associations with demographics and cognitive measures than the classical temporal meta-ROI. The gene discussed is MAPT; the disease is Alzheimer disease.